Pamela Stephenson - 25 Jun 2021 Form 4 Insider Report for ALBIREO PHARMA, INC.

Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
25 Jun 2021
Net transactions value
-$16,961
Form type
4
Filing time
28 Jun 2021, 16:02:48 UTC
Next filing
05 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $16,961 -471 -1.7% $36.01 26,514 25 Jun 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 10,076 shares of common stock and 16,438 restricted stock units.